« Guru of the Week - Pate Kane and the Play Ethic |
Main
| Celebrating Obsessive Art »
April 6, 2004
FutureGuru Sees the Neurosociety
Posted by Zack Lynch
James Canton, CEO of the Institute for Global Futures, is interviewed in US News' Friday Forward column where he describes some of the critical issues he sees emerging in the coming decades. Here is a snippet:
"Next News: What trends do you see developing over the next 10 to 25 years that the average person today has little awareness of?
Canton: The major future trend that will affect everyone in business in the future is the emergence of the innovation economy. Innovation will be the currency of the future marketplace, offsetting the outsourcing trend. Those that know how to use tech innovations to create customer value will win. The fastest innovation will be driven by the convergence of four power toolsnanotech, biotech, infotech, and cognitive science. They will offer a new gold rush of opportunity. Leveraging the new building blocks of innovation comprised of bits, atoms, genes, and neurons will be essential for future leaders . . .
The real sleeper trend is neurodrugs for enhancing human cognition, augmenting memory, and increasing intelligence. Human and health enhancement will be the largest marketplace in the 21st century, driven by the aging and affluent baby boomers who will want to invest in their own longevity"live long and prosper."
Next News: What magazines or Web sites do you read that the average person may not have heard of?
Canton: I get Issues in Science and Technology, I subscribe to the NeuroSociety Online Blog by Zack Lynch and I get NASAs Astrobiology newsletter."
As I've mentioned before, James gets it.
Comments (0)
+ TrackBacks (0) | Category: Neurosociety
- RELATED ENTRIES
- Neurotech 2010: Translational Researchers Highlight Innovation
- The Neuro Revolution in China Progressing
- Speakers for Neurotech 2010 - Boston, May 19-20
- Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
- McGovern Institue for Brain Research at MIT Goes Web 2.0
- The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
- Neuropharma FDA Approvals Down in 2009
- Tel Aviv Neurotech Cluster Thrives